Jupiter Bioventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses

- Jupiter Bioventures will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib for Radioprotection in the US, Europe, Japan, and All Other.

Jupiter bioventuresDavid buttaroJack baileyGenor biopharmaNathaniel davidGain exclusive rights for the clinical developmentResearch triangle parkExchange commissionTherapeutics incNational medical products administrationCorporate communicationsGain exclusive rightsClinical developmentRegulatory submissionsDeimos biosciencesManaging director

G1 Therapeutics And Deimos Biosciences In License Deal For Lerociclib For Radioprotective Uses

(RTTNews) - G1 Therapeutics, Inc. (GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures,.

Genor biopharmaJupiter bioventuresTherapeutics incNational medical products administrationDeimos biosciencesDeimos biosciencePepper bio

Tempus Announces Dr Ned Sharpless as a Senior Strategic Advisor

Tempus Announces Dr Ned Sharpless as a Senior Strategic Advisor
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dana farber cancer instituteUnited statesNormane ned sharplessEric lefkofskyErin carronJupiter bioventuresNational institutes of healthSchool of medicineUniversity of north carolinaLineberger comprehensive cancer centerNational cancer instituteHarvard medical schoolDrug administrationNational academy of medicineAmerican association of physiciansNational institutes

Repeat CT: Unraveling Plaque Changes in CAD With Elevated Lp(a)

The study "represents the beginning of our understanding of the role of Lp(a) in plaque progression," leading experts in lipoprotein(a) say.

New yorkUnited statesUnited kingdomNoord hollandJupiter bioventuresMarcr dweckColl cardiolSotirios tsimikasJagat narulaSir jules thorn award for biomedical researchUniversity of amsterdamBritish heart foundationUniversity of california san diegoIcahn school of medicine at mount sinaiJournal of the american college cardiologyIonis pharmaceuticals

Mission BioCapital Closes Fund V, at $275M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomSan franciscoUnited statesMichaeld taylorCassidy blundellSteve tregayRobert blazejEric linsleyJupiter bioventuresJohannes fruehaufPeterd parkerJennifer griffinPionyr immunotherapeuticsDoug crawfordArclight therapeuticsMission biocapital